Your browser doesn't support javascript.
loading
Cost-effective analysis of clopidogrel versus aspirin for high risk patients with established peripheral arterial disease in China.
Lin, Ziyi; Zhang, Lei; Yang, Xiaoyan; Liu, Li; Xuan, Jianwei.
Affiliation
  • Lin Z; Health Economics Department, Shanghai Centennial Scientific, Shanghai, China.
  • Zhang L; Health Economics Department, Shanghai Centennial Scientific, Shanghai, China.
  • Yang X; Health Economics and Outcome Research, Sanofi, Shanghai, China.
  • Liu L; Health Economics and Outcome Research, Sanofi, Shanghai, China.
  • Xuan J; Health Economics Research Institute, Sun Yat-sen University, Guangzhou, China.
J Med Econ ; 23(6): 659-666, 2020 Jun.
Article in En | MEDLINE | ID: mdl-31999196
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Aspirin / Secondary Prevention / Peripheral Arterial Disease / Clopidogrel Type of study: Etiology_studies / Health_economic_evaluation / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Med Econ Year: 2020 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 Database: MEDLINE Main subject: Platelet Aggregation Inhibitors / Aspirin / Secondary Prevention / Peripheral Arterial Disease / Clopidogrel Type of study: Etiology_studies / Health_economic_evaluation / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Med Econ Year: 2020 Document type: Article